Skip to content
Screener

Alkermes ALKS Net Income

Net Income at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$3.32B+153%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$293.1M+417%
AbbVie logo
AbbVieABBV
$3.61B+285%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
-$64.54M-8.6%
Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
$89M+89.4%
LBR
LB Pharmaceuticals IncLBRX
-$19.05M-259%

Other financials

Income statement

See full
Revenue$496.0M+27.0%
Gross profit$397.9M+16.6%
Operating income$18.4M-80.3%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$511.5M-1.9%
Total debt$1.6B+2,064%
Total equity$1.8B+11.3%
Total assets$4.4B+95.0%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$8.1M-37.4%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$8.32B+89.9%
Enterprise value$9.38B+139%
P/E125.9×+113×
P/S+2.1×

Profitability

See full
Gross margin84.6%-0.6pp
Operating margin7%-17.8pp
Net margin4%-19.2pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity3.9%-20.1pp
Debt / equity0.9×+0.8×
Current ratio2.3×-0.9×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: Alkermes’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 9:22 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-319022
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Total other (expense) income, net(20,229)11,861(33,875)23,558
(LOSS) INCOME BEFORE INCOME TAXES(1,876)104,839(63,802)130,328
INCOME TAX PROVISION (BENEFIT)(2,377)17,7412,17720,766
NET (LOSS) INCOME$501$87,098$(65,979)$109,562
(LOSS) EARNINGS PER ORDINARY SHARE:
(Loss) earnings per ordinary share—basic$0.00$0.53$(0.40)$0.67
(Loss) earnings per ordinary share—diluted$0.00$0.52$(0.40)$0.65
WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES OUTSTANDING:

Item 1. Condensed Consolidated Financial Statements:

FAQ

What is Alkermes's net income?
Alkermes (ALKS) reported net income of $501K in Q2 2026.
How has Alkermes's net income changed year-over-year?
Alkermes's net income decreased by 99.4% year-over-year, from $87.1M to $501K.
What is the long-term trend for Alkermes's net income?
Over 4 years (2021 to 2025), Alkermes's net income has grown at a 49.0% compound annual growth rate (CAGR), from -$49.04M to $241.66M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Ask your AI about Alkermes's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude